In particular, neutralising (IgG) auto-antibodies against IFN-I, appear to contribute to severe forms of COVID-19 by antagonising innate antiviral responses [70,71], but also anti-ACE2 non-neutralising (IgM) auto-antibodies have been recently associated with severe clinical complications in some COVID-19 patients [72]. Here, ACE2 is linked to COVID-19.